Transparency on clinical trial costs must become the norm to improve access to medical products worldwide.

Safeguarding children against TB takes center stage with introduction of child-friendly formulation of rifapentine for short-course TB preventive treatment.

The dictionary aims to unify TB-related terminology and promote clearer communication by providing a common language for researchers, policy-makers, donors and affected communities.

On World TB Day, WHO is calling for action on several fronts to ensure that the commitments made to end TB are achieved. A special newsletter edition compiles all WHO advocacy activities and key resources released in the lead-up to World TB Day.

With less than a year to go until the 1/4/6x24 Campaign deadline, the Getting Better Faster: Delivering on the Promise of New TB Treatments report outlines both progress made and remaining gaps toward achieving 1/4/6x24.

The TB Vax ARM outlines three key advocacy wins for the field to achieve by 2026 in order to effectively advance TB vaccine development. Check them out and sign a petition to show your support!

TB advocates protest outside the headquarters of Danaher in Washington, DC, demanding price drop to $5 per test.

Results UK’s new advocacy report presents the case for adopting a whole of society approach to ending TB, focused on addressing the underlying social causes of TB alongside curing the physical disease.

Nearly 7,000 excess deaths from TB occurred in the WHO European Region in the three years of the pandemic from 2020-2022, compared to what experts had expected based on pre-2020 estimates.

On World TB Day, WHO is calling for action on several fronts to ensure that the commitments made to end TB are achieved. WHO releases an advocacy and communications World TB Day campaign package.